Atopic eruption of pregnancy (AEP) is the most common skin condition specific to pregnancy, accounting for roughly half of all pregnancy-related dermatoses. It is an umbrella term that groups together eczematous changes, prurigo-type papules, and pruritic folliculitis that develop during pregnancy in women with an underlying tendency toward atopic (allergy-prone) skin. AEP tends to appear earlier than other pregnancy-specific rashes and is not dangerous to the baby, but it can cause intense itching that significantly affects daily life and sleep.
What AEP Actually Includes
The term “atopic eruption of pregnancy” was introduced after researchers studying hundreds of pregnant patients noticed that three conditions previously considered separate, namely eczema in pregnancy, prurigo of pregnancy, and pruritic folliculitis of pregnancy, shared so much overlap that drawing firm lines between them was impractical.1PubMed. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients Rather than treating each as its own disease, the reclassification gathered them under one diagnosis linked by a shared atopic background.
This reclassification was not without controversy. Some dermatologists argue that prurigo of pregnancy and pruritic folliculitis deserve their own diagnostic categories because their clinical appearances and courses can differ. But in practice, the AEP umbrella has gained traction because most patients share key features: itchy skin, a personal or family history of atopic conditions like asthma or hay fever, and onset relatively early in pregnancy.
The Two Main Appearance Patterns
AEP does not look the same on everyone. Clinicians broadly divide it into two visual patterns. The eczema type (sometimes called E-type) shows up as patchy, red, scaly areas that look like classic eczema, affecting about 47% of people with AEP. The papular type (P-type) presents as small, scattered, firm bumps or prurigo-style nodules, usually on the shins and arms, and accounts for about 33% of cases.2Austin Journal of Dermatology. Atopic Eruption of Pregnancy: A Recent, but Controversial Classification The remaining portion includes folliculitis-predominant presentations, where the bumps center around hair follicles and can resemble acne.
E-type AEP gravitates toward the typical eczema zones: the insides of the elbows, behind the knees, the neck, and the face. P-type lesions are more widely scattered across the trunk and limbs. Both types itch, sometimes severely, and scratching can lead to thickened, roughened skin over time. Recognizing which pattern you have helps your dermatologist tailor treatment, but the underlying management approach is similar for both.
When It Shows Up and Who Gets It
One of the most useful features for distinguishing AEP from other pregnancy rashes is timing. AEP commonly begins earlier than conditions like polymorphic eruption of pregnancy (PEP) or pemphigoid gestationis, which typically appear in the third trimester. Roughly 36% of AEP cases start in the first trimester and another 40% in the second trimester, meaning most women notice it well before the final stretch of pregnancy.3Austin Journal of Dermatology. Atopic Eruption of Pregnancy: A Recent, but Controversial Classification This early onset is a hallmark that clinicians rely on during diagnosis.
About 80% of women diagnosed with AEP have never had eczema before and are experiencing it for the first time during pregnancy. The remaining 20% already had eczema that flared up once they became pregnant, sometimes severely enough to cause widespread redness across the body.4Austin Journal of Dermatology. Atopic Eruption of Pregnancy: A Recent, but Controversial Classification That split is important: if you have never been diagnosed with eczema, AEP can still appear seemingly out of nowhere during pregnancy. The atopic tendency may have been present all along without causing visible skin problems until pregnancy tipped the balance.
Recurrence is also common. About one in three women who develop AEP report a similar rash in a previous pregnancy, which suggests the hormonal and immune environment of pregnancy reliably triggers the condition in susceptible people.
Why Pregnancy Sets It Off
Pregnancy reshapes the immune system in ways that favor certain types of inflammation over others. The body shifts toward an immune profile that helps tolerate the genetically foreign fetus, but this same shift happens to promote the type of immune response involved in allergic and atopic conditions. For women who already carry that atopic tendency, pregnancy essentially amplifies it. Atopic dermatitis frequently worsens during pregnancy because of these hormone-driven immune changes.5Dermatologic Therapy. The Intersection of Inflammatory Skin Diseases and Women’s Reproductive Health: Challenges in Managing Psoriasis and Atopic Dermatitis During Pregnancy and Hormonal Fluctuations
Genetics play a role too, particularly mutations in the filaggrin gene. Filaggrin is a protein critical for maintaining the skin’s outer barrier. People who carry filaggrin mutations tend toward drier, more fragile skin that lets irritants and allergens in more easily. One study found that women with filaggrin mutations faced a dramatically higher risk of eczema flares during pregnancy, with roughly ten times the odds compared to women without such mutations.6PubMed. The role of filaggrin mutations during pregnancy and postpartum: atopic dermatitis and genital skin diseases The combination of an already compromised skin barrier and the immune upheaval of pregnancy creates a perfect setup for AEP to emerge.
How AEP Is Diagnosed
There is no single blood test or biopsy result that definitively confirms AEP. Diagnosis relies on a combination of clinical features: the appearance of the rash, its timing during pregnancy, and evidence of an atopic background such as a personal or family history of eczema, asthma, or allergic rhinitis. Serum IgE (an antibody associated with allergic conditions) is sometimes measured, but it is not consistently elevated. In one study of prurigo-type patients, only about one in five tested showed raised IgE levels.7Clinics in Dermatology. Prurigo, pruritic folliculitis, and atopic eruption of pregnancy: Facts and controversies A normal IgE result does not rule out AEP.
Skin biopsy can support the diagnosis but will not settle it on its own. Under the microscope, AEP typically shows inflammation around blood vessels with a notable presence of eosinophils, a type of white blood cell linked to allergic reactions. One histopathological study found eosinophils in 74% of AEP biopsies. However, the researchers also found no definitive microscopic features that could reliably separate AEP from polymorphic eruption of pregnancy, making the clinical picture and timing of onset essential for accurate diagnosis.8The American Journal of Dermatopathology. Histopathological Diagnosis of Atopic Eruption of Pregnancy and Polymorphic Eruption of Pregnancy: A Study on 41 Cases
Telling AEP Apart from Other Pregnancy Rashes
Several other skin conditions are specific to pregnancy, and confusing them with AEP can lead to unnecessary worry or, in some cases, missed diagnoses that actually matter for the baby’s health. The three most important conditions to distinguish from AEP are polymorphic eruption of pregnancy (PEP), pemphigoid gestationis (PG), and intrahepatic cholestasis of pregnancy (ICP).
PEP, also called pruritic urticarial papules and plaques of pregnancy, usually appears in the third trimester and favors first-time mothers carrying multiples. It typically starts within the stretch marks on the abdomen and spreads outward, giving it a recognizable distribution that differs from the limb-and-flexure pattern of AEP. PEP is also benign and does not affect the baby, but it tends to emerge later in pregnancy and rarely recurs in subsequent pregnancies.
Pemphigoid gestationis is much rarer and more serious. It involves autoantibodies that attack the skin’s basement membrane, producing tense blisters that usually start around the navel. Unlike AEP, PG carries a small risk of prematurity and low birth weight and requires closer obstetric monitoring. If blisters develop alongside intense itching, the diagnosis shifts away from AEP.
Intrahepatic cholestasis of pregnancy stands apart because itching occurs without a primary rash. Women with ICP feel intense, generalized itching, especially on the palms and soles, but the skin looks normal apart from scratch marks. Bile acid levels in the blood are elevated, and the condition carries real risks for the baby, including preterm birth and stillbirth. Any pregnant woman with severe generalized itching and no visible rash should have liver function and bile acid tests to rule out ICP before accepting a diagnosis of AEP.
Treatment During Pregnancy
Managing AEP involves a stepwise approach, starting with gentle skin care and escalating to medications only when needed. Because many drugs carry uncertain safety profiles during pregnancy, the goal is to control symptoms with the mildest effective intervention.
Skin Care and Lifestyle Adjustments
The foundation of AEP management is restoring and protecting the skin barrier. Liberal use of fragrance-free moisturizers applied immediately after bathing helps seal in moisture and reduce the dryness that drives itching. Avoiding common triggers matters too: hot showers, harsh soaps, synthetic fabrics, and overheating can all worsen symptoms. Loose cotton clothing and keeping the bedroom cool at night can make a noticeable difference in itch intensity. These steps sound simple, but for many women with mild AEP, consistent skin care is enough to keep the condition tolerable without medication.
Topical Treatments
When moisturizers alone are not enough, mild to moderate topical corticosteroids are the standard first-line medication. Low-potency steroid creams applied to affected areas for limited periods are considered safe in pregnancy and are effective at reducing inflammation and itch. Higher-potency steroids may be used briefly on thick plaques or stubborn patches, but prolonged use of potent formulations is avoided because of potential effects on skin thinning and, at very high doses, theoretical systemic absorption.
Topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, are sometimes considered for sensitive areas like the face or skin folds where long-term steroid use is undesirable. Their safety data in pregnancy is more limited than that of corticosteroids, so they tend to be reserved for situations where steroids are not appropriate.
Systemic Options for Severe Cases
A small number of women develop AEP severe enough that topical treatments cannot control it. In those cases, systemic therapy becomes necessary. Oral antihistamines, particularly the older sedating types like chlorpheniramine, can help with nighttime itching and are generally regarded as safe during pregnancy. Among stronger systemic options, cyclosporine is the best-studied immunosuppressant for use in pregnant women with severe atopic dermatitis. Safety data on newer biologic drugs approved for eczema remain limited to small case series, so their use during pregnancy is approached cautiously and typically only in specialized settings.9PubMed. Atopic dermatitis and pregnancy
Oral corticosteroids (such as prednisolone) may be prescribed for short courses during severe flares, though repeated or prolonged use is avoided due to risks like gestational diabetes and preterm birth at higher cumulative doses.
Phototherapy and a Hidden Concern About Folate
Narrowband ultraviolet B (NB-UVB) phototherapy is widely regarded by dermatologists as a safe option for treating skin conditions during pregnancy. It does not involve systemic drugs, and the UV light targets the skin directly. For women with moderate-to-severe AEP who want to avoid medications, phototherapy sessions two to three times per week can reduce inflammation and itching.
There is, however, an underappreciated issue. NB-UVB phototherapy can lower folate levels in the blood. One study found that after 30 treatment sessions, the average serum folate level in patients dropped by roughly half.10PubMed Central. The effect of narrowband ultraviolet B phototherapy on serum folate level Folate is critical during pregnancy for preventing neural tube defects in the developing baby. The study’s authors recommended that women of childbearing age receiving NB-UVB phototherapy should take folic acid supplements. For pregnant women already on phototherapy for AEP, this is a practical concern worth discussing with your care team: folic acid supplementation should be confirmed and folate levels may need monitoring over a prolonged treatment course.
What Happens After Delivery
AEP generally improves after birth, though the timeline varies. Some women see their rash clear within days of delivery; others find it takes several weeks for symptoms to fully resolve. Unlike pemphigoid gestationis, which can flare dramatically in the immediate postpartum period, AEP tends to wind down as pregnancy hormones recede and the immune system gradually shifts back toward its pre-pregnancy state.
For the roughly 20% of women who had pre-existing eczema before pregnancy, the postpartum period does not always bring complete relief. Their baseline eczema may persist or return to its pre-pregnancy severity, requiring ongoing management. Breastfeeding also introduces its own considerations for treatment choices, since some topical steroids applied to the nipple area could be ingested by the infant. Switching to a non-medicated nipple cream and applying topical treatments only to other body areas during breastfeeding is a common practical adjustment.
Women who carry filaggrin mutations face an additional postpartum concern. Beyond the eczema itself, the same skin barrier weakness associated with filaggrin mutations was linked to prolonged physical problems related to perineal trauma during delivery.11PubMed. The role of filaggrin mutations during pregnancy and postpartum: atopic dermatitis and genital skin diseases This suggests that the compromised skin barrier affects healing more broadly, not just in the areas where eczema is visible.
Does AEP Affect the Baby’s Risk of Developing Allergies
This is a question that many women with AEP naturally wonder about, and the honest answer is that we do not have strong direct evidence linking AEP itself to an increased risk of atopic disease in the child. What we do know is that atopy in general runs in families. If you develop AEP, you carry an atopic predisposition, and that predisposition has a genetic component that can be passed on. A child born to one parent with eczema, asthma, or hay fever already has an elevated chance of developing similar conditions compared to a child with no family history.
AEP as an umbrella entity is defined in part by the presence of an atopic background in the mother.12Clinics in Dermatology. Prurigo, pruritic folliculitis, and atopic eruption of pregnancy: Facts and controversies But whether the pregnancy flare itself, beyond the underlying genetics, adds extra risk to the baby’s allergic future has not been clearly established. The practical takeaway is that if you have AEP, your child’s pediatrician should be aware of your atopic history so that early signs of eczema or food allergy in the infant can be recognized and managed promptly.
Why AEP Is Likely Underdiagnosed
Despite being the most common pregnancy-specific skin condition, AEP flies under the radar more than it should. Several factors contribute. First, many women and even some general practitioners dismiss pregnancy-related itching as a normal discomfort, so mild cases never get evaluated. Second, the 80% of AEP patients who have never had eczema before may not connect a new rash to an atopic condition, especially if they have no personal history of asthma or hay fever. Third, there is no definitive lab test or biopsy finding for AEP, which means diagnosis depends on pattern recognition by a clinician familiar with pregnancy dermatoses. General obstetricians may not see enough of these cases to feel confident distinguishing AEP from other itchy rashes.
The risk of underdiagnosis is not just missed comfort. When AEP goes unrecognized, more serious conditions like intrahepatic cholestasis of pregnancy may also be missed, because the clinical workup that would catch cholestasis (bile acid testing) is only triggered when itching is taken seriously and evaluated systematically. A pregnant woman whose itching is brushed off as “just pregnancy skin” may miss the chance for an early diagnosis that could change obstetric management.
If you are pregnant and dealing with persistent itching that disrupts your sleep or daily routine, requesting a referral to a dermatologist experienced in pregnancy-related conditions is reasonable. Early identification of AEP not only opens the door to effective treatment but also ensures that the differential diagnosis is properly explored.